World Health Organization Issues Concern Over Acute Lack of Weight-Loss Medications
Under 10% of patients eligible to benefit from weight-loss injections such as Wegovy have access to them, caution the global health agency as it releases its first advice on the medications.
With more than one billion people worldwide now living with obesity, it is calling for more widespread and fairer access to this class of drugs.
Based on forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 if no action is taken.
"Our new guidelines recognises that obesity is a lifelong illness that can be treated with thorough and lifelong support," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and distribution challenges are major hurdles to universal availability to the injections that can aid individuals in losing significant body mass, explains the organization.
GLP-1 Therapy Scarcity
Even under the present most optimistic case, the production of these medications would only suffice for about 100 million people – under 10% of those who need them, as stated by the WHO.
The advice urges nations and manufacturers to expand access, through strategies such as patent sharing.
The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is scheduled to end in multiple nations in 2026.
How Weight-Loss Jabs Function
GLP-1 drugs mimick a natural hormone to delay gastric emptying, curb appetite and boost the sense of being full so people consume fewer calories.
Patients commonly see weight reduction after several weeks of beginning the once-weekly jabs.
Research suggests users may see weight return after a year of discontinuing the medication, because their usual hunger resume.
Being overweight or obese increases your likelihood for experiencing health problems, like type 2 diabetes, heart disease, brain attack, and specific cancers.
Excess weight impacts people in every country and was linked to millions of deaths worldwide in 2024, as per the WHO.
